COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Protein-Protein Interactions in Human Disease, Part B - 1st Edition - ISBN: 9780128143421, 9780128143438

Protein-Protein Interactions in Human Disease, Part B, Volume 111

1st Edition

Serial Volume Editor: Rossen Donev
Hardcover ISBN: 9780128143421
eBook ISBN: 9780128143438
Imprint: Academic Press
Published Date: 17th February 2018
Page Count: 294
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Homo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design
Sitanshu S. Singh and Seetharama D. Jois
2. Targeting Intramembrane Protein–Protein Interactions: Novel Therapeutic Strategy of Millions Years Old
Alexander B. Sigalov
3. Targeting the Architecture of Deregulated Protein Complexes in Cancer
Eduard Stefan, Jakob Troppmair and Klaus Bister
4. Multifaceted Nucleolin Protein and Its Molecular Partners in Oncogenesis
Iva Ugrinova, Maria Petrova, Mounira Chalabi-Dchar and Philippe Bouvet
5. Subcellular Targeting of Nitric Oxide Synthases Mediated by Their N-Terminal Motifs
Carlos Costas-Insua, Javier Merino-Gracia, Clara Aicart-Ramos and Ignacio Rodríguez-Crespo
6. Development of Protein–Protein Interaction Inhibitors for the Treatment of Infectious Diseases
Andrew F. Voter and James L. Keck
7. Defining Pharmacological Targets by Analysis of Virus–Host Protein Interactions
Manuel Llano and Mario A. Peña-Hernandez
8. Investigating the Influence of Hotspot Mutations in Protein–Protein Interaction of IDH1 Homodimer Protein: A Computational Approach
D. Thirumal Kumar, P. Sneha, Jennifer Uppin, S. Usha and C. George Priya Doss
9. Human Interactomics: Comparative Analysis of Different Protein Interaction Resources and
Construction of a Cancer Protein–Drug Bipartite Network
Javier De Las Rivas, Diego Alonso-López and Mónica M. Arroyo


Protein-Protein Interactions in Human Disease, Volume 111, Part B, promotes further research and development in the protein interaction network in order to identify critical proteins involved in the etiology of human diseases and locate new protein targets for drug development. Thus, this volume is of considerable interest to protein chemists, pharmacologists, cell biologists, immunologists, structural biologists, computational biochemists and other researchers working in the field. In addition, these articles would be of great benefit to medical, biology and pharmacology students who specialize in this field.

Key Features

  • Describes advances in the application of powerful techniques in studying and analyzing protein-protein interactions
  • Ideal for a wide audience of researchers, specialists and students
  • Written by authorities in their field
  • Contains a number of high quality illustrations, figures and tables that support the presented information


Protein chemists, pharmacologists, cell biologists, immunologists, structural biologists, computational biochemists and other researchers working in this field. Articles published here would also be of great benefit to medical, biology and pharmacology students specializing in this field


No. of pages:
© Academic Press 2018
17th February 2018
Academic Press
Hardcover ISBN:
eBook ISBN:

Ratings and Reviews

About the Serial Volume Editor

Rossen Donev

Rossen Donev

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.

Affiliations and Expertise

Swansea University, UK